Connecting Molecules to Medicine™

See What Makes Nexus Pharmaceuticals Different

Through our commitment to innovative R&D, Nexus Pharmaceuticals identifies off-patent and difficult to formulate molecules that can be developed, improved upon, and commercialized to advance industry standards and deliver on critical medical needs.

Is your pharmaceutical manufacturer a certified diverse supplier?

New State-of-the-Art Manufacturing Facility located in Pleasant Prairie, WI 

Commitment to Quality
From Molecules to Medicine

Opening in Summer 2021

State-of-the-Art Sterile Injectable Manufacturing Facility

Located in Pleasant Prairie, Wisconsin, we broke ground in 2019 to build Project Tomorrow, a state-of-the-art sterile injectable manufacturing facility to support the production and supply of injectable drugs in various therapeutic areas including anesthesiology, oncology, cardiology, and neurology. We plan to invest $250 million over the next ten years and create over 400 jobs in total.


Parkside Athletics Announces Partnership with Nexus

Nexus is proud to partner with the University of Wisconsin-Parkside and Parkside Athletics in support of their #RangerVision2020 campaign to secure a brighter future for student-athletes, the Parkside Athletics program, and the Wisconsin community.

read more

Find out what we’re about

Discover more about Nexus Pharmaceuticals and get in touch today!